Eurogentec

What Eurogentec does

Eurogentec (legal entity Kaneka Eurogentec S.A.) is a Belgian life science manufacturing company headquartered in Seraing, Belgium, founded in 1985 and operating as a wholly-owned subsidiary of Japan's Kaneka Corporation since 2006. The company runs GMP-accredited and FDA-inspected production facilities exceeding 10,000 m², supplying catalog and custom nucleic acid reagents, peptides, antibodies, recombinant proteins, qPCR kits, and CDMO services spanning therapeutic oligonucleotides, GMP IVT-mRNA (up to 50g per batch, equivalent to 100,000s to millions of doses), plasmid DNA, and VHH antibody fragments at kilogram scale.

Its technology stack centers on proprietary oligonucleotide synthesis with extensive modification capability (ASO, siRNA, NGS oligos, aptamers), an in-house rapid VHH/nanobody manufacturing platform from camelid immunization through GMP production, large-scale IVT mRNA synthesis and purification, and a portfolio of IP-free ATTO dyes for qPCR and dPCR probe applications. The offering combines high-purity catalog products (over 1,000 catalog peptides, Takyon® qPCR kits, MapMarker® ladders) with quote-based custom synthesis and multi-year contract manufacturing for clinical and commercial human therapeutics.

Eurogentec generates revenue across five streams: catalog and custom oligonucleotide product sales, GMP CDMO services for pharma and biotech clients, custom antibody and VHH production, custom peptide synthesis, and reagents/assay kits. Pricing is unit-based for catalog research products and quote-based for custom synthesis and GMP manufacturing, with multi-year contracting common for CDMO and OEM kit engagements. Customers are segmented across pharmaceutical/biotech (primary), diagnostics (primary), and academic/research institutions, served globally from Belgium via direct field sales for BLA-grade contracts and e-commerce for research-grade consumables, supplemented by a regional distributor network.

Name

Eurogentec

Legal name

Kaneka Eurogentec S.A.

Website

https://eurogentec.com

Company type

Private

Founded year

1985

Operating status

Operating

Headcount range

251–500 employees

Short description

Eurogentec is a Belgian GMP-accredited, FDA-inspected CDMO and life science reagents manufacturer producing catalog and custom oligonucleotides, mRNA, peptides, antibodies, and recombinant proteins for pharmaceutical, diagnostic, and academic customers globally as a subsidiary of Kaneka Corporation.

Ownership category

akta.pro rank

Product category

Biopharmaceutical CDMO and Life Science Reagents

NAICS

Pharmaceutical Preparation Manufacturing (325412), Biological Product (except Diagnostic) Manufacturing (325414), Pharmaceutical and Medicine Manufacturing (3254), In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

Pharmaceutical Preparations (2834), Biological Products, (No Disgnostic Substances) (2836), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

mRNA/LNP & Nucleic Acid Therapeutics CDMO (HLAGABAF)

akta.pro secondary industries

Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK), Gene Therapy (Viral Vector/Plasmid) CDMO (HLAGABAE), Biologics (mAbs/Recombinant Proteins) CDMO (HLAGABAC), Gene Therapy Vector Manufacturing & CDMO Services (HLAAACAJ)

Keywords

• Oligonucleotide synthesis
• GMP mRNA manufacturing
• CDMO services
• Custom peptide synthesis
• Antibody development

Headquarters

HQ city

Seraing-le-château

HQ country

Belgium

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Oligonucleotide Products: Catalog and custom oligonucleotides including research oligos, diagnostic oligos, ASR oligos, and pre-clinical/therapeutic oligos. Revenue from product sales of various purity grades and modifications.
2. GMP CDMO Services: Contract development and manufacturing services for pharmaceutical companies including GMP mRNA synthesis, plasmid DNA manufacturing, therapeutic peptides, and antibody fragment production for clinical trials and commercialization.
3. Antibody Products and Services: Custom polyclonal and monoclonal antibody development, VHH development, and industrial-scale antibody production services.
4. Peptide Products: Custom peptide synthesis and catalog peptides including modified peptides, fluorescent labeled peptides, and GMP peptides for research and clinical applications.
5. Reagents and Assay Kits: qPCR kits, extraction/purification kits, electrophoresis systems, labeling reagents, and assay kits for research applications.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

Eurogentec manufactures and sells life-science reagents (catalog and custom oligonucleotides, peptides, antibodies, recombinant proteins, qPCR kits) and provides GMP contract development and manufacturing organization (CDMO) services for mRNA, plasmid DNA, therapeutic oligonucleotides, and antibody fragments. Its products serve pharmaceutical, biotech and diagnostic customers from research through clinical and commercial stages of nucleic acid and protein therapeutics development.

Product overview

Eurogentec is a Belgian biotech company and contract development and manufacturing organization (CDMO) founded in 1985, operating under the Kaneka Group. The company offers a comprehensive portfolio of life science research reagents and GMP manufacturing services. The product portfolio centers on oligonucleotides (catalog and custom synthesis including RNA/DNA oligos, siRNA, ASO, probes, and specialized oligos), peptides (custom synthesis and 1,000+ catalog peptides), antibodies (custom polyclonal/monoclonal production and VHH/nanobody services), recombinant proteins, and qPCR/RT-qPCR reagent kits. The CDMO services division provides GMP manufacturing of therapeutic oligonucleotides, mRNA (up to 50g batch scale), peptides, and plasmid DNA/recombinant proteins for clinical and commercial applications. The company operates over 10,000 m² of production area and is GMP accredited with FDA inspection capability.

Differentiator

Problem solved

Functional benefit

Products and services

• Oligonucleotides (Oligos) Catalog and custom oligonucleotides including research oligos, diagnostic/testing oligos, ASR oligos, and pre-clinical/therapeutic oligos with various modifications, purifications, and scales, sold to researchers, diagnostics developers, and therapeutic developers.
• Custom Oligos Custom oligonucleotide manufacturing offering backbones, modifications, purifications, additional QC, custom format and packaging, and OEM kit manufacturing for diagnostics and research customers.
• Probes qPCR and dPCR probes including Double-Dye Probes, MGB Probes, Molecular Beacons, and IP-friendly Dyes and Quenchers, with design assistance, for diagnostics developers and molecular biology researchers.
• RNAi Products RNA interference products including custom siRNA duplexes, siRNA controls, and miRNA mimics and inhibitors, for gene silencing research and therapeutic development.
• Specialized Oligos Advanced oligonucleotide products including ASO oligos, oligos for screening, peptide-oligonucleotide conjugates, complex oligos, large scale oligos, oligo aptamers, and NGS oligos, for therapeutic developers and advanced research applications.
• GMP IVT-RNA Manufacturing GMP-grade in vitro transcription RNA manufacturing service for clinical and commercial applications, with capacity up to 50g per batch, serving pharmaceutical and biotech customers developing mRNA therapeutics and vaccines.
• GMP Therapeutic Oligonucleotides GMP synthesis of therapeutic oligonucleotides for pre-clinical and clinical use, serving pharmaceutical and biotech developers of nucleic acid therapeutics.
• GMP Peptide Manufacturing GMP-grade custom peptide synthesis for therapeutic and diagnostic applications, serving pharmaceutical and biotech customers advancing peptide-based drugs through clinical development.
• Takyon® qPCR Kits Quantitative PCR reagent kits for probe assays and SYBR® assays including Takyon® Etheris for microbial qPCR and MMx for complex samples and multiplexing, for diagnostics labs and research users.
• Quantitative Reverse Transcription PCR Kits One-step and two-step RT-qPCR kits for gene expression analysis, virus detection, and multiplexing applications, for diagnostics and research laboratories.
• Endpoint PCR Products PCR reagents including PCR mixes, DNA polymerases, reverse transcriptase, and dNTP mixes for endpoint PCR applications, for molecular biology research and diagnostic workflows.
• Antibody Production Services Custom polyclonal and monoclonal antibody production services, including hybridoma development, VHH development, and industrial-scale GMP antibody fragment manufacturing, for diagnostics developers and pharmaceutical researchers.
• GMP VHH Antibody Manufacturing GMP production of VHH (nanobody) antibody fragments, from camelid immunization through purification, serving pharmaceutical and biotech customers developing nanobody therapeutics and diagnostics.
• Custom Peptide Synthesis Custom peptide synthesis services including fluorescent-labeled peptides, FRET peptides, cyclic peptides, stapled peptides, phosphorylated peptides, and peptide libraries, for research and preclinical therapeutic development.
• Catalog Peptides Collection of over 1,000 catalog peptides across 12 research areas including neuroscience, cardiovascular, diabetes, cancer, immunology, epigenetics, and hormones, with ≥95% HPLC purity, for life science researchers.
• Assay Kits Ready-to-use assay kits for neuroscience, cardiovascular research, cancer research, cell biology, viral/bacterial proteases, diabetes, and ELISA applications, for academic and pharma research laboratories.
• Recombinant Proteins Catalog recombinant proteins for neuroscience, cardiovascular, adhesion, and epigenetics research, including GMP recombinant proteins for clinical use, serving research and pharmaceutical customers.
• Large Scale GMP BioManufacturing Plasmid DNA, recombinant proteins, and antibody fragment production up to kilogram scale for clinical and commercial human use, serving pharmaceutical and biotech customers requiring GMP biomanufacturing capacity.
• MapMarker® Fluorescent dye-labeled molecular weight ladder for electrophoresis applications, sold to molecular biology research and diagnostics labs.
• ATTO Dyes IP-free ATTO dyes for qPCR and dPCR probe applications with an extended selection, for diagnostics developers and researchers building probe panels.

Quantifiable outcome

• 50g mRNA per single batch - equivalent to 100,000s to millions of mRNA doses

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Kaneka GroupcoreOthersEurogentec is a subsidiary of Kaneka Group, a Japanese chemical and pharmaceutical company. Kaneka Eurogentec operates as the Belgian entity within the larger Kaneka organization, providing life science and biotech solutions globally.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Market position

Strengths4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/eurogentec
• Facebookfacebook.com/eurogentec
• LinkedInlinkedin.com/company/eurogentec

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Eurogentec